---
$id: https://graph.org.ai/products/commodity/51281628
$type: Product
source: UNSPSC
code: "51281628"
title: "Capreomycin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Capreomycin

**UNSPSC Code**: 51281628
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitubercular agent and aminoglycoside antibiotic with the molecular formula C19H30N12O6(R1)(R2), a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 232HYX66HC, more generally known as capreomycin. European Medicines Agency schedules capreomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01028MIG. The term CAPREOMYCIN is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 19 1975, list 5. CAPREOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule capreomycin under HS 29419000 and SITC 54139. As of Q4 2014, CAPREOMYCIN remains the US FDA Preferred Term for this commodity. Capreomycin bears US NLM identifiers UMLS ID C0262964 and NCI Concept Code C72607. SMILES: CC1C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)NC(C(=O)NCC(C(=O)N1)N)C2CCN=C(N2)N)CNC(=O)CC(CCCN)N.C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CNC(=O)CC(CCCN)N)CO)N)N.

